Verastem, Inc.

VSTMNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
6.03 USD
↗ 0.26 (4.51%)AT CLOSE (11:59 AM EDT)
5.90
↘ 0.13 (2.16%)
POST MARKET (AS OF 05:17 PM EDT)
Post Market
AS OF 05:17 PM EDT
5.90
↘ 0.13 (2.16%)
🟢Market: OPEN

Verastem, Inc. (VSTM) trades at $5.65 per share. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jul 17, 2026.

Open?$5.70
High?$6.07
Low?$5.56
Prev. Close?$5.77
Volume?3.6M
Avg. Volume?3.0M
VWAP?$5.83
Rel. Volume?1.20x
Bid / Ask
Bid?$6.01 × 100
Ask?$6.09 × 100
Spread?$0.08
Midpoint?$6.05
Valuation & Ratios
Market Cap?507.0M
Shares Out?87.9M
Float?81.9M
Float %?93.2%
P/E Ratio?N/A
P/B Ratio?6.20
EPS?-$2.21
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Themes
Healthcare - Oncology›Targeted Therapy & Precision Oncology
Employees
102
Market Cap
507.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.verastem.com
Listed
2012-01-27
Address
117 KENDRICK STREET
NEEDHAM, MA 02494
Phone: (781) 292-4200
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
73
Short Sent.?
11
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.84Distress
Confidence?47%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?29.47%Squeeze Risk
Short Interest?24.1M
Days to Cover?7.0
Free Float81.9M
Avg Daily Volume3.5M
Settlement Date2026-06-30
Financial Health
Current Ratio?3.04Strong
Quick Ratio?3.00Strong
Cash Ratio?2.48Strong
Debt/Equity?1.01Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
30
6.20FAIR▾
P/S?
Peers
100
S&P
8
10.23HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.5CHEAP▾
EV/Sales?
Peers
100
S&P
15
8.55HIGH▾
Returns & Efficiency
ROE?
S&P
3
-237.2%WEAK▾
ROA?
S&P
3
-85.1%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$424.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist